Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vasculogenic mimicry (VM) is a phenomenon observed in aggressive tumors where cancer cells form vascular-like channels and networks that facilitate blood supply to the tumor, independent of traditional angiogenesis. These tumor-derived channels can transport plasma and red blood cells, supporting rapid tumor growth and metastasis. The presence of VM correlates with poor prognosis: increased metastasis risk, higher tissue invasion rates, resistance to anti-angiogenic therapies, and overall worse patient survival outcomes.
N/A
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vasculogenic Mimicry Formation.